IL-6 and Type 2 Diabetes
Background: Interleukin -6 (IL-6) as the key mediator of the acute phase reaction is of interest .elevated protein concentrations of IL-6 in the blood have been shown in patients with type 2 diabetes. This study aimed to investigate the association of IL-6 and type 2 diabetes. Materials and Method...
Main Author: | Maha F. Almelan |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine University of Baghdad
2010-01-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/1095 |
Similar Items
-
A study to assess diabetic distress and other factors which affect glycemic control in patients with type 2 diabetes mellitus
by: Amruthavarshini Nagabhushana, et al.
Published: (2021-01-01) -
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
by: Munir KM, et al.
Published: (2016-04-01) -
The Frequency of Type 2 Diabetes Mellitus among Diabetic Children in El Minia Governorate, Egypt
by: Basma A. Ali, et al.
Published: (2013-08-01) -
Telehealth and Type 2 Diabetes Management
by: Ikpeama, Blessing Nneoma
Published: (2019) -
The effect of vitamin D deficiency on serum sIL-2R, IL-6 and TNF-alpha levels in adults with Type 1 diabetes
by: Mehmet Türken, et al.
Published: (2015-12-01)